What is he best known for?
The fields of study he is best known for:
- Immune system
- Gene
- Cytokine
Jacques Banchereau focuses on Immunology, Immune system, CD40, Cell biology and Antigen.
His Immunology and Dendritic cell, Antigen-presenting cell, Immunotherapy, Immunity and Antigen presentation investigations all form part of his Immunology research activities.
His work investigates the relationship between Antigen presentation and topics such as Dendritic cell differentiation that intersect with problems in Dendritic cell migration.
His CD40 study combines topics in areas such as Molecular biology, Cell type, Cellular differentiation and Follicular dendritic cells.
In his work, Langerin is strongly intertwined with MHC class II, which is a subfield of Cell biology.
His Antigen study incorporates themes from Progenitor cell and Adjuvant.
His most cited work include:
- Dendritic cells and the control of immunity (12817 citations)
- Immunobiology of Dendritic Cells (5916 citations)
- Taking dendritic cells into medicine (1720 citations)
What are the main themes of his work throughout his whole career to date?
Jacques Banchereau mostly deals with Immunology, Antigen, Molecular biology, Immune system and Cell biology.
His work in Immunology is not limited to one particular discipline; it also encompasses Cytotoxic T cell.
Many of his studies involve connections with topics such as Virology and Antigen.
His studies deal with areas such as Cell culture, CD40, B cell, Receptor and Interleukin 4 as well as Molecular biology.
His research in CD40 intersects with topics in Interleukin 12, B-cell receptor and Germinal center.
His Cell biology study integrates concerns from other disciplines, such as In vitro, Cellular differentiation and Follicular dendritic cells.
He most often published in these fields:
- Immunology (54.26%)
- Antigen (25.29%)
- Molecular biology (24.52%)
What were the highlights of his more recent work (between 2012-2021)?
- Immunology (54.26%)
- Immune system (25.54%)
- Antigen (25.29%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Immunology, Immune system, Antigen, Virology and T cell.
His Immunology research incorporates themes from Cancer and Transcriptome.
His Immune system study combines topics from a wide range of disciplines, such as CD34, Peripheral blood mononuclear cell, In vivo and Cell biology.
The study incorporates disciplines such as Cytokine and CD40 in addition to Antigen.
His study in Virology is interdisciplinary in nature, drawing from both Epitope, Antibody and Antigen-presenting cell.
His Antigen-presenting cell research is multidisciplinary, incorporating perspectives in Germinal center and Antigen presentation.
Between 2012 and 2021, his most popular works were:
- Dendritic-cell-based therapeutic cancer vaccines. (528 citations)
- Induction of ICOS+CXCR3+CXCR5+ TH cells correlates with antibody responses to influenza vaccination. (396 citations)
- Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients. (317 citations)
In his most recent research, the most cited papers focused on:
- Immune system
- Gene
- Cytokine
His primary areas of study are Immunology, Immune system, Antigen, Cancer and Vaccination.
His Immunology study deals with Cellular differentiation intersecting with Transforming growth factor beta.
Jacques Banchereau interconnects Cytotoxic T cell and Peripheral blood mononuclear cell in the investigation of issues within Immune system.
His Antigen study often links to related topics such as CD40.
Jacques Banchereau works mostly in the field of Cancer, limiting it down to topics relating to Adoptive cell transfer and, in certain cases, Oncology, Internal medicine, Monoclonal antibody and Cell.
His study looks at the intersection of Vaccination and topics like Acquired immune system with Plasma cell, Common variable immunodeficiency, Autoimmunity, Adjuvant and Salmonella enterica.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
